Hugel Expands Its Aesthetic Portfolio with ECM-Based Injectable Treatments Hugel Inc. enhances its medical aesthetics offerings by entering the ECM-based injectable market, collaborating with Hans Biomed to distribute CellREDM™.

Hugel Expands Its Aesthetic Portfolio with ECM-Based Injectable Treatments #South_Korea #Seoul #Hugel_Inc #CellREDM #Hans_Biomed

Hugel Achieves Record Annual Financial Results in 2025 with Exceptional Growth In 2025, Hugel Inc. reached unprecedented financial heights with annual net sales exceeding KRW425 billion, driven by booming demand and global expansion.

Hugel Achieves Record Annual Financial Results in 2025 with Exceptional Growth #South_Korea #Seoul #Botulax #Hugel_Inc #THE_CHAEUM

Hugel Sees Stellar Growth with Record Net Sales in H1 2025 Hugel Inc. achieved impressive financial results in H1 2025, posting over KRW200 billion in net sales, driven by strong overseas demand and cosmetics growth.

Hugel Sees Stellar Growth with Record Net Sales in H1 2025 #South_Korea #Seoul #Hugel_Inc #Hyaluronic_Acid #Botulinum_Toxin

Hugel Inc. Unveils Ambitious Growth Goals at J.P. Morgan Healthcare Conference Hugel Inc. aims for global leadership in medical aesthetics by 2028, bolstered by a comprehensive strategy presented at the J.P. Morgan Healthcare Conference.

Hugel Inc. Unveils Ambitious Growth Goals at J.P. Morgan Healthcare Conference #United_States #San_Francisco #J.P._Morgan #Medical_Aesthetics #Hugel_Inc